Moreover, Antonangeli et al. reported that the upregulation of PD-L1 in cancer cells is controlled via NF-κB downstream of several signals, including oncogene- and cell stress-induced pathways, inflammatory cytokines, and chemotherapeutic drugs [143]. Here, CD274 is linked to cancer.